The ISAR Study Group2020-06-022020-06-022020-04The ISAR Study Group 2020, 'International Severe Asthma Registry : Mission Statement', Chest, vol. 157, no. 4, pp. 805-814. https://doi.org/10.1016/j.chest.2019.10.0510012-3692https://hdl.handle.net/2164/14423FUNDING/SUPPORT: ISAR is conducted by Optimum Patient Care Global (OPC) Limited, and cofunded by OPC Limited and AstraZeneca10545951engISARsevere asthmaDEFINITIONOMALIZUMABCOSTSADULTSPHENOTYPESPREVALENCER Medicine (General)Critical Care and Intensive Care MedicineCardiology and Cardiovascular MedicinePulmonary and Respiratory MedicineR1Journal article10.1016/j.chest.2019.10.051http://www.scopus.com/inward/record.url?scp=85082137760&partnerID=8YFLogxK1574